These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 692284)

  • 41. Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.
    Tyce GM; Rorie DK
    Life Sci; 1985 Dec; 37(25):2439-48. PubMed ID: 4079658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
    Kihara T; Ikeda M; Matsushita A
    Brain Res; 1990 Jun; 519(1-2):44-9. PubMed ID: 2397417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment.
    Racagni G; Bruno F; Bugatti A; Parenti M; Apud JA; Santini V; Carenzi A; Groppetti A; Cattabeni F
    Adv Biochem Psychopharmacol; 1980; 24():45-51. PubMed ID: 7405672
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L; Kaakkola S
    Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
    Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATP induces release of newly synthesized dopamine in the rat striatum.
    Zhang YX; Yamashita H; Ohshita T; Sawamoto N; Nakamura S
    Neurochem Int; 1996 Apr; 28(4):395-400. PubMed ID: 8740447
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.
    Miller HH; Shore PA
    Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
    Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
    Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biphasic influence of a 8 alpha-amino ergoline, CU 32-085, on striatal dopamine synthesis and turnover in vivo in the rat.
    Enz A
    Life Sci; 1981 Nov; 29(21):2227-34. PubMed ID: 6119592
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J; Coviella IL; Wurtman RJ
    Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
    Millington WR; Wurtman RJ
    Eur J Pharmacol; 1982 Jun; 80(4):431-4. PubMed ID: 7106193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in dopamine metabolism after chronic administration of haloperidol. Possible role of increased autoreceptor sensitivity.
    Saller CF; Salama AI
    Neuropharmacology; 1985 Feb; 24(2):123-9. PubMed ID: 3990917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of phencyclidine on dopamine synthesis and metabolic in rat striatum.
    Doherty JD; Simonovic M; So R; Meltzer HY
    Eur J Pharmacol; 1980 Jul; 65(2-3):139-49. PubMed ID: 7398783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A simple, sensitive method for measuring 3,4-dihydroxyphenylacetic acid and homovanillic acid in rat brain tissue using high-performance liquid chromatography with electrochemical detection.
    Hefti F
    Life Sci; 1979 Aug; 25(9):775-81. PubMed ID: 491856
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Ichikawa J; Meltzer HY
    Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical effects of quipazine on rat striatal dopaminergic system.
    Ponzio F; Consolazione A; Calderini G; Achilli G; Rocchetti M; Algeri S
    Life Sci; 1981 Jul; 29(1):83-91. PubMed ID: 7266263
    [No Abstract]   [Full Text] [Related]  

  • 59. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.